ELTP
Elite Pharmaceuticals, Inc.
Set alert
0.23 USD 0.00 0.00%
0.22 Day range 0.233
0.21 52-week range 0.69
- YTD
- -53.06%
- 1 year
- -62.30%
- Open
- 0.23
- Prev close
- 0.23
- Mkt cap
- 247.74M
- Vol
- 503.23K
- Avg vol
- 817.00K
- EPS
- 0.04
- P/E
- 5.75
More statistics
- Low
- 0.22
- High
- 0.233
Financials — quick view
ELTP Revenue — quarterly 8.98M
ELTP Net income — quarterly 1.14M
ELTP EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Feb 14, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
- Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
- ELTP Downgraded to Neutral on Pricing Pressure & Limited Visibility
- ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
- Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y
- Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript
- Elite Pharmaceuticals Q1 Earnings Call Highlights
- Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026
- Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
- Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below Two Hundred Day Moving Average – Time to Sell?
Your note
Sign in to keep a note on ELTP — it syncs with the Stock Master app.